ARIAD Pharmaceuticals Inc.

(ARIA) Trade

By |

Profile

Ariad Pharmaceuticals is a biotechnology company with a focus on cancer drugs. The global oncology company aims to discover, develop, and commercialize small-molecule medicines to treat aggressive cancers where current therapies are inadequate, including leukemia. The vast majority of Ariad's revenue is derived from its product revenue segment, followed by its license collaboration and other revenue segments. The United States represents a majority of the company? oncology profits based on roughly half of its global sales. Ariad seeks market share outside the U.S. through industry partnerships.

Contact Information

Website: www.ariad.com
Email: manmeet.soni@ariad.com
Main Phone: +1 617 494-0400
Address: 26 Landsdowne Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139-4234

Issuer Information

Exchange: NGS
CEO: Paris Panayiotopoulos
Employees: 459
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 23.99 52 Wk Low 4.67
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 194,200,862.00 EPS (TTM) -0.18 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Paris Panayiotopoulos 1,000
Paris Panayiotopoulos 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Sarah J. Schlesinger 1,000
Sarah J. Schlesinger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Last 10 Sell Shares
Timothy P. Clackson 1,000
Daniel M. Bollag 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 20.43 20.43 20.43 20.43
Standard Deviation 6.63 6.63 6.63 6.63
Date of Most Recent Estimate 01/11/17 01/11/17 01/11/17 01/11/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 2 5 5
Moderate Buy 0 0 0 0
Hold 6 6 2 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 2 2
Mean Rec. 2.71 2.5 2.33 2.14